QQQ $ 433.04 $ 1.75 (0.41 %)
DIA $ 383.81 $ 1.49 (0.39 %)
SPY $ 510.06 $ 1.80 (0.35 %)
TLT $ 88.99 $ 0.74 (0.84 %)
GLD $ 216.18 $ -0.44 (-0.2 %)
$ 0.585
-- x --
-- x --
-- - --
$ 0.49 - $ 32.87
6,821
na
na
$ 1.87
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-motus-gi-holdings-shares-are-trading-lower-by-around-46-here-are-20-stocks-moving-premarket

Shares of Motus GI Holdings, Inc. (NASDAQ: MOTS) shares fell sharply in pre-market trading after the company priced its $5 mi...

 what-ebix-incs-financial-struggles-mean-for-ebixcash-and-its-india-ipo-ambitions

This story was first published on the Benzinga India portal.

 nasdaq-gains-100-points-biomerica-shares-spike-higher

U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining over 100 points on Monday. The D...

 why-lantheus-holdings-shares-are-trading-lower-by-over-22-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma ann...

 crude-oil-rises-3-us-housing-market-index-increases-in-december

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 50 points on Monday. The Dow traded ...

 ebix-shares-resume-trade
Ebix Shares Resume Trade
12/18/2023 15:57:48

 why-arcutis-biotherapeutics-shares-are-trading-higher-by-around-25-here-are-20-stocks-moving-premarket

Shares of Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) rose sharply in pre-market trading after the FDA approved company’s ZOR...

 ebix-q3-earnings-insights
Ebix: Q3 Earnings Insights
11/14/2023 14:15:06

 ebix-q3-adj-eps-011-misses-007-estimate-sales-11923m-miss-12428m-estimate

Ebix (NASDAQ:EBIX) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $0.07 by 257.1...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION